Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma

Cancer

Volumn 94, Issue 7, 2002, Pages 1955-1960

  Tachibana, Mitsuo ^a   Shibakita, Muneaki ^a   Ohno, Satoshi ^a   Kinugasa, Shoichi ^a   Yoshimura, Hiroshi ^a   Ueda, Shuhei ^a   Fujii, Toshiyuki ^a   Rahman, Mohammad A ^a   Dhar, Dipok K ^a   Nagasue, Naofumi ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Clinicopathologic features; Esophageal carcinoma; Long term survival; PTEN; Tumor suppressor gene

Indexed keywords

BIOLOGICAL MARKER; CYTOPLASM PROTEIN; NUCLEAR PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; TUMOR CLASSIFICATION; TUMOR SUPPRESSOR GENE;

EID: 0036533982     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.0678     Document Type: Article

References (39)

1. Loss of the chromosomal region 10q23-25 in prostate cancer
2. Allelic loss on chromosome 10q in human lung cancer: Association with tumour progression and metastatic phenotype
3. Allelotype study of esophageal carcinoma
4. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
5. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
6. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β
7. Germline mutations of the PTEN gene in Cowen disease, an inherited breast and thyroid cancer syndrome
8. Germline mutation in PTEN are present in Bannayan-Zonana syndrome
9. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain
10. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer
11. PTEN is essential for embryonic development and tumour suppression
12. Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: Relationship to prognostic significance
13. Differential expression of MMAC/PTEN in glioblastoma multiforme: Relationship to localization and prognosis
14. Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations
15. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma
16. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines
17. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors
18. PTEN/MMAC1 mutations in endometrial cancers
19. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies
20. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma
21. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer
22. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage
23. Mutations of PTEN/MMAC1 in primary prostate cancers from Chinese patients
24. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas
25. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers
26. Genotypic analysis of tumor suppressor genes PTEN/MMAC1 and p53 in head and neck squamous cell carcinomas
27. Loss of heterozygosity at 10q in tumors of the upper respiratory tract is associated with poor prognosis
28. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines
29. Analysis of the PTEN gene mutation in polyposis syndromes and sporadic gastrointestinal tumors in Japanese patients
30. Mutation analysis of the PTEN/MMAC1 gene in cancers of the digestive tract
31. Mutational analysis of the PTEN/MMAC1 gene in primary oesophageal squamous cell carcinomas
32. PTEN/MMAC1 expression in esophageal squamous cell carcinomas
33. The general rules for the gastric cancer study in surgery and pathology
34. Prognostic factors in T1 and T2 squamous cell carcinoma of the thoracic esophagus
35. Nonparametric estimation for incomplete observation
36. Parameters linked to ten-year survival in Japan of resected esophageal carcinoma
37. National Cancer Data Base report on esophageal carcinoma
38. Regulations of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway